CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 149 (1-2) , 182-186
- https://doi.org/10.1016/j.jneuroim.2003.12.010
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis opticaNeurology, 2004
- The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)Seminars in Immunology, 2003
- Pure optic-spinal form of multiple sclerosis in Japan.Brain, 2002
- A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis opticaBrain, 2002
- IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the diseaseJournal of the Neurological Sciences, 2002
- Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosisEuropean Journal of Neurology, 2001
- CCR5+and CXCR3+T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesionsProceedings of the National Academy of Sciences, 1999
- Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patientsJournal of Clinical Investigation, 1999
- Chemokines — Chemotactic Cytokines That Mediate InflammationNew England Journal of Medicine, 1998
- Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.Journal of Neurology, Neurosurgery & Psychiatry, 1996